,approvedSymbol,approvedName,prefName,drugType,drugId,phase,ctIds,id,disease
0,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,[],MONDO_0005180,Parkinson disease
1,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
2,CHRM3,cholinergic receptor muscarinic 3,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0005180,Parkinson disease
3,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0005180,Parkinson disease
4,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
5,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
6,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,"['NCT00174239', 'NCT00642356']",MONDO_0005180,Parkinson disease
7,DRD3,dopamine receptor D3,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0005180,Parkinson disease
8,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
9,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,4.0,['NCT00477802'],MONDO_0005180,Parkinson disease
10,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
11,SCN3A,sodium voltage-gated channel alpha subunit 3,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
12,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
13,CACNA1B,calcium voltage-gated channel subunit alpha1 B,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00584025'],MONDO_0005180,Parkinson disease
14,ADRA1A,adrenoceptor alpha 1A,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
15,SCN1A,sodium voltage-gated channel alpha subunit 1,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
16,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT01244269'],MONDO_0005180,Parkinson disease
17,DRD4,dopamine receptor D4,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
18,SCN10A,sodium voltage-gated channel alpha subunit 10,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
19,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,"['NCT04952194', 'NCT06013956', 'NCT06236230']",MONDO_0005180,Parkinson disease
20,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
21,ADRA2A,adrenoceptor alpha 2A,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
22,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
23,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,VARENICLINE,Small molecule,CHEMBL1076903,4.0,['NCT02473562'],MONDO_0005180,Parkinson disease
24,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
25,GABRD,gamma-aminobutyric acid type A receptor subunit delta,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
26,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
27,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
28,SCN9A,sodium voltage-gated channel alpha subunit 9,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
29,CHRM1,cholinergic receptor muscarinic 1,TRIHEXYPHENIDYL,Small molecule,CHEMBL1490,4.0,[],MONDO_0005180,Parkinson disease
30,DRD4,dopamine receptor D4,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0005180,Parkinson disease
31,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,VARENICLINE,Small molecule,CHEMBL1076903,4.0,['NCT02473562'],MONDO_0005180,Parkinson disease
32,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
33,MAOB,monoamine oxidase B,SAFINAMIDE MESYLATE,Small molecule,CHEMBL48582,4.0,['NCT05312632'],MONDO_0005180,Parkinson disease
34,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
35,AVPR1A,arginine vasopressin receptor 1A,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
36,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
37,DRD3,dopamine receptor D3,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT02233023', 'NCT01673724']",MONDO_0005180,Parkinson disease
38,HRH1,histamine receptor H1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
39,DRD3,dopamine receptor D3,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0005180,Parkinson disease
40,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0005180,Parkinson disease
41,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
42,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02688465', 'NCT02549573']",MONDO_0005180,Parkinson disease
43,HRH1,histamine receptor H1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
44,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
45,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,[],MONDO_0005180,Parkinson disease
46,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT00174239', 'NCT00642356']",MONDO_0005180,Parkinson disease
47,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
48,DRD2,dopamine receptor D2,DOMPERIDONE,Small molecule,CHEMBL219916,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
49,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
50,DRD5,dopamine receptor D5,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
51,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02549573', 'NCT02688465']",MONDO_0005180,Parkinson disease
52,SCN3A,sodium voltage-gated channel alpha subunit 3,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
53,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
54,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0005180,Parkinson disease
55,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
56,MTNR1A,melatonin receptor 1A,MELATONIN,Small molecule,CHEMBL45,4.0,"['NCT03258294', 'NCT02768077']",MONDO_0005180,Parkinson disease
57,DRD2,dopamine receptor D2,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0005180,Parkinson disease
58,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0005180,Parkinson disease
59,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
60,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
61,MAOB,monoamine oxidase B,SAFINAMIDE MESYLATE,Small molecule,CHEMBL48582,4.0,[],MONDO_0005180,Parkinson disease
62,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0005180,Parkinson disease
63,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
64,MTNR1B,melatonin receptor 1B,MELATONIN,Small molecule,CHEMBL45,4.0,"['NCT02768077', 'NCT03258294']",MONDO_0005180,Parkinson disease
65,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT04387773', 'NCT01313845', 'NCT01071395', 'NCT00632762']",MONDO_0005180,Parkinson disease
66,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,4.0,['NCT04373317'],MONDO_0005180,Parkinson disease
67,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
68,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
69,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
70,SCN5A,sodium voltage-gated channel alpha subunit 5,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
71,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
72,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02940912', 'NCT01770145']",MONDO_0005180,Parkinson disease
73,SCN8A,sodium voltage-gated channel alpha subunit 8,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
74,DRD1,dopamine receptor D1,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
75,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,"['NCT00219284', 'NCT00391898', 'NCT00906828', 'NCT00888186', 'NCT02480803', 'NCT00590122', 'NCT00143026', 'NCT03115827', 'NCT00141518', 'NCT00125567']",MONDO_0005180,Parkinson disease
76,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT02549573'],MONDO_0005180,Parkinson disease
77,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
78,CHRM1,cholinergic receptor muscarinic 1,METHIXENE,Small molecule,CHEMBL1201342,4.0,[],MONDO_0005180,Parkinson disease
79,SCN8A,sodium voltage-gated channel alpha subunit 8,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
80,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0005180,Parkinson disease
81,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,4.0,['NCT00399477'],MONDO_0005180,Parkinson disease
82,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT00321854', 'NCT02233023', 'NCT01673724', 'NCT03521635', 'NCT02231905', 'NCT00402233']",MONDO_0005180,Parkinson disease
83,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0005180,Parkinson disease
84,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
85,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
86,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0005180,Parkinson disease
87,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0005180,Parkinson disease
88,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0005180,Parkinson disease
89,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0005180,Parkinson disease
90,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
91,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0005180,Parkinson disease
92,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,['NCT01856738'],MONDO_0005180,Parkinson disease
93,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,[],MONDO_0005180,Parkinson disease
94,SCN5A,sodium voltage-gated channel alpha subunit 5,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
95,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,[],MONDO_0005180,Parkinson disease
96,DRD3,dopamine receptor D3,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
97,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,[],MONDO_0005180,Parkinson disease
98,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,['NCT04821687'],MONDO_0005180,Parkinson disease
99,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
100,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,4.0,"['NCT00030979', 'NCT01521117']",MONDO_0005180,Parkinson disease
101,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
102,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0005180,Parkinson disease
103,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02688465', 'NCT02549573']",MONDO_0005180,Parkinson disease
104,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT00485069', 'NCT01494532', 'NCT01485172', 'NCT00986245']",MONDO_0005180,Parkinson disease
105,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
106,AVPR2,arginine vasopressin receptor 2,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
107,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
108,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,[],MONDO_0005180,Parkinson disease
109,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
110,SCN3A,sodium voltage-gated channel alpha subunit 3,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
111,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT00696215', 'NCT01385735', 'NCT01765257', 'NCT01007630']",MONDO_0005180,Parkinson disease
112,CHRM1,cholinergic receptor muscarinic 1,ETHOPROPAZINE,Small molecule,CHEMBL1206,4.0,[],MONDO_0005180,Parkinson disease
113,MAOB,monoamine oxidase B,RASAGILINE TARTRATE,Small molecule,CHEMBL5315052,4.0,[],MONDO_0005180,Parkinson disease
114,DDC,dopa decarboxylase,BENSERAZIDE,Small molecule,CHEMBL1096979,4.0,['NCT02741947'],MONDO_0005180,Parkinson disease
115,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
116,SCN11A,sodium voltage-gated channel alpha subunit 11,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
117,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,['NCT00601978'],MONDO_0005180,Parkinson disease
118,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
119,SCN4A,sodium voltage-gated channel alpha subunit 4,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
120,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,[],MONDO_0005180,Parkinson disease
121,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0005180,Parkinson disease
122,SCN2A,sodium voltage-gated channel alpha subunit 2,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
123,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
124,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
125,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE TARTRATE,Small molecule,CHEMBL215645,4.0,[],MONDO_0005180,Parkinson disease
126,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN TARTRATE,Small molecule,CHEMBL2448613,4.0,[],MONDO_0005180,Parkinson disease
127,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
128,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0005180,Parkinson disease
129,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT00321854', 'NCT00402233', 'NCT02231905', 'NCT02233023', 'NCT01673724', 'NCT03521635']",MONDO_0005180,Parkinson disease
130,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,"['NCT04986995', 'NCT04990284']",MONDO_0005180,Parkinson disease
131,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,['NCT06115538'],MONDO_0005180,Parkinson disease
132,CHRM1,cholinergic receptor muscarinic 1,PROCYCLIDINE,Small molecule,CHEMBL86715,4.0,[],MONDO_0005180,Parkinson disease
133,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
134,COMT,catechol-O-methyltransferase,TOLCAPONE,Small molecule,CHEMBL1324,4.0,[],MONDO_0005180,Parkinson disease
135,CHRM1,cholinergic receptor muscarinic 1,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0005180,Parkinson disease
136,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,"['NCT00141518', 'NCT02480803', 'NCT00590122', 'NCT00143026', 'NCT03115827', 'NCT00888186', 'NCT00219284', 'NCT00906828', 'NCT00125567', 'NCT00391898']",MONDO_0005180,Parkinson disease
137,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0005180,Parkinson disease
138,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,['NCT04990284'],MONDO_0005180,Parkinson disease
139,CHRM1,cholinergic receptor muscarinic 1,BENZTROPINE MESYLATE,Small molecule,CHEMBL1200383,4.0,[],MONDO_0005180,Parkinson disease
140,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0005180,Parkinson disease
141,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
142,BCHE,butyrylcholinesterase,RIVASTIGMINE TARTRATE,Small molecule,CHEMBL215645,4.0,[],MONDO_0005180,Parkinson disease
143,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0005180,Parkinson disease
144,SCN7A,sodium voltage-gated channel alpha subunit 7,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
145,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
146,SCN8A,sodium voltage-gated channel alpha subunit 8,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
147,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
148,SCN10A,sodium voltage-gated channel alpha subunit 10,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
149,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
150,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
151,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT00526630'],MONDO_0005180,Parkinson disease
152,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01071395', 'NCT01313845', 'NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
153,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT00632762', 'NCT01071395', 'NCT04387773', 'NCT01313845']",MONDO_0005180,Parkinson disease
154,HTR2C,5-hydroxytryptamine receptor 2C,METHIXENE,Small molecule,CHEMBL1201342,4.0,[],MONDO_0005180,Parkinson disease
155,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
156,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0005180,Parkinson disease
157,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0005180,Parkinson disease
158,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT01485172', 'NCT00485069', 'NCT00986245', 'NCT01494532']",MONDO_0005180,Parkinson disease
159,COMT,catechol-O-methyltransferase,TOLCAPONE,Small molecule,CHEMBL1324,4.0,['NCT00906828'],MONDO_0005180,Parkinson disease
160,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01313845', 'NCT00632762', 'NCT04387773', 'NCT01071395']",MONDO_0005180,Parkinson disease
161,HTR2C,5-hydroxytryptamine receptor 2C,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0005180,Parkinson disease
162,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
163,CHRM3,cholinergic receptor muscarinic 3,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0005180,Parkinson disease
164,CHRM2,cholinergic receptor muscarinic 2,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0005180,Parkinson disease
165,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0005180,Parkinson disease
166,AVPR1B,arginine vasopressin receptor 1B,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
167,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
168,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
169,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
170,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0005180,Parkinson disease
171,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,[],MONDO_0005180,Parkinson disease
172,AVPR1A,arginine vasopressin receptor 1A,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
173,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
174,SV2A,synaptic vesicle glycoprotein 2A,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00307450'],MONDO_0005180,Parkinson disease
175,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0005180,Parkinson disease
176,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
177,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,4.0,[],MONDO_0005180,Parkinson disease
178,DRD2,dopamine receptor D2,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0005180,Parkinson disease
179,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,['NCT00601978'],MONDO_0005180,Parkinson disease
180,SLC6A2,solute carrier family 6 member 2,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
181,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
182,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
183,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
184,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0005180,Parkinson disease
185,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
186,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
187,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0005180,Parkinson disease
188,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
189,SCN11A,sodium voltage-gated channel alpha subunit 11,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
190,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
191,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,4.0,[],MONDO_0005180,Parkinson disease
192,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
193,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0005180,Parkinson disease
194,SCN10A,sodium voltage-gated channel alpha subunit 10,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
195,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
196,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0005180,Parkinson disease
197,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
198,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,4.0,[],MONDO_0005180,Parkinson disease
199,CHRM1,cholinergic receptor muscarinic 1,BENZTROPINE,Small molecule,CHEMBL1201203,4.0,[],MONDO_0005180,Parkinson disease
200,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,"['NCT01340885', 'NCT03840837', 'NCT00988117']",MONDO_0005180,Parkinson disease
201,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,"['NCT00247247', 'NCT00373087', 'NCT02847442', 'NCT00125567', 'NCT00219284', 'NCT00143026', 'NCT00391898', 'NCT00906828']",MONDO_0005180,Parkinson disease
202,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT00485069', 'NCT01485172', 'NCT00986245', 'NCT01494532']",MONDO_0005180,Parkinson disease
203,SCN7A,sodium voltage-gated channel alpha subunit 7,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
204,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0005180,Parkinson disease
205,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0005180,Parkinson disease
206,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0005180,Parkinson disease
207,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,['NCT04986982'],MONDO_0005180,Parkinson disease
208,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0005180,Parkinson disease
209,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
210,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT00526630'],MONDO_0005180,Parkinson disease
211,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
212,SV2A,synaptic vesicle glycoprotein 2A,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00584025'],MONDO_0005180,Parkinson disease
213,VDR,vitamin D receptor,CHOLECALCIFEROL,Small molecule,CHEMBL1042,4.0,['NCT00571285'],MONDO_0005180,Parkinson disease
214,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT01048229', 'NCT01178047']",MONDO_0005180,Parkinson disease
215,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0005180,Parkinson disease
216,DRD4,dopamine receptor D4,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0005180,Parkinson disease
217,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT01721460', 'NCT02256319', 'NCT01789385']",MONDO_0005180,Parkinson disease
218,DRD2,dopamine receptor D2,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0005180,Parkinson disease
219,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,"['NCT01340885', 'NCT03840837', 'NCT00988117']",MONDO_0005180,Parkinson disease
220,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,['NCT01856738'],MONDO_0005180,Parkinson disease
221,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,['NCT00601978'],MONDO_0005180,Parkinson disease
222,HTR2A,5-hydroxytryptamine receptor 2A,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0005180,Parkinson disease
223,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0005180,Parkinson disease
224,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT00888186', 'NCT00485069', 'NCT02769793', 'NCT00141518', 'NCT00399477', 'NCT00914134', 'NCT02741947', 'NCT00906828', 'NCT00125567', 'NCT00590122', 'NCT00219284', 'NCT00153972', 'NCT00391898', 'NCT02847442', 'NCT00272688', 'NCT00143026', 'NCT02480803', 'NCT01770145']",MONDO_0005180,Parkinson disease
225,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,4.0,"['NCT00590122', 'NCT03151460', 'NCT02233023']",MONDO_0005180,Parkinson disease
226,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
227,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
228,SCN1A,sodium voltage-gated channel alpha subunit 1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
229,AVPR2,arginine vasopressin receptor 2,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
230,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT00632762', 'NCT04387773']",MONDO_0005180,Parkinson disease
231,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
232,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0005180,Parkinson disease
233,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,"['NCT03843944', 'NCT03841604', 'NCT05312632']",MONDO_0005180,Parkinson disease
234,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0005180,Parkinson disease
235,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
236,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0005180,Parkinson disease
237,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
238,SCN5A,sodium voltage-gated channel alpha subunit 5,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
239,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0005180,Parkinson disease
240,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
241,ADRA1B,adrenoceptor alpha 1B,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
242,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
243,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
244,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT01789385', 'NCT01721460', 'NCT02256319']",MONDO_0005180,Parkinson disease
245,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0005180,Parkinson disease
246,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0005180,Parkinson disease
247,SCN11A,sodium voltage-gated channel alpha subunit 11,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
248,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,[],MONDO_0005180,Parkinson disease
249,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
250,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,['NCT00153972'],MONDO_0005180,Parkinson disease
251,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
252,ADRB3,adrenoceptor beta 3,MIRABEGRON,Small molecule,CHEMBL2095212,4.0,['NCT02092181'],MONDO_0005180,Parkinson disease
253,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT01244269'],MONDO_0005180,Parkinson disease
254,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0005180,Parkinson disease
255,DRD2,dopamine receptor D2,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
256,MAOB,monoamine oxidase B,SELEGILINE,Small molecule,CHEMBL972,4.0,"['NCT00443872', 'NCT00640159', 'NCT04870372']",MONDO_0005180,Parkinson disease
257,CHRM1,cholinergic receptor muscarinic 1,BIPERIDEN,Small molecule,CHEMBL1101,4.0,[],MONDO_0005180,Parkinson disease
258,SCN4A,sodium voltage-gated channel alpha subunit 4,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
259,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
260,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT01744496', 'NCT00594464', 'NCT01782222', 'NCT01300819', 'NCT03103919', 'NCT01711866', 'NCT01523301']",MONDO_0005180,Parkinson disease
261,CACNA1B,calcium voltage-gated channel subunit alpha1 B,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00307450'],MONDO_0005180,Parkinson disease
262,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT02549573'],MONDO_0005180,Parkinson disease
263,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,['NCT00601978'],MONDO_0005180,Parkinson disease
264,ADRB3,adrenoceptor beta 3,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
265,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT04387773', 'NCT00632762', 'NCT01071395', 'NCT01313845']",MONDO_0005180,Parkinson disease
266,SCN2A,sodium voltage-gated channel alpha subunit 2,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
267,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0005180,Parkinson disease
268,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT06234995', 'NCT06013956', 'NCT04952194', 'NCT06236230']",MONDO_0005180,Parkinson disease
269,ADRA2C,adrenoceptor alpha 2C,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
270,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,['NCT00642356'],MONDO_0005180,Parkinson disease
271,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,4.0,['NCT03011476'],MONDO_0005180,Parkinson disease
272,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
273,DRD4,dopamine receptor D4,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT02233023', 'NCT01673724']",MONDO_0005180,Parkinson disease
274,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0005180,Parkinson disease
275,ADRB1,adrenoceptor beta 1,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
276,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
277,SCN9A,sodium voltage-gated channel alpha subunit 9,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
278,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,[],MONDO_0005180,Parkinson disease
279,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT01770145', 'NCT02940912']",MONDO_0005180,Parkinson disease
280,GABRP,gamma-aminobutyric acid type A receptor subunit pi,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
281,SCN1A,sodium voltage-gated channel alpha subunit 1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
282,SCN9A,sodium voltage-gated channel alpha subunit 9,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
283,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT00594464', 'NCT01711866', 'NCT03103919', 'NCT01782222', 'NCT01300819', 'NCT01523301', 'NCT01744496']",MONDO_0005180,Parkinson disease
284,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,4.0,['NCT02472210'],MONDO_0005180,Parkinson disease
285,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT03521635', 'NCT00402233', 'NCT02231905', 'NCT02233023', 'NCT00321854', 'NCT01673724']",MONDO_0005180,Parkinson disease
286,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01313845', 'NCT00632762', 'NCT01071395', 'NCT04387773']",MONDO_0005180,Parkinson disease
287,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0005180,Parkinson disease
288,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0005180,Parkinson disease
289,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
290,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0005180,Parkinson disease
291,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
292,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0005180,Parkinson disease
293,AVPR1B,arginine vasopressin receptor 1B,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
294,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,['NCT00174239'],MONDO_0005180,Parkinson disease
295,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,4.0,['NCT01216904'],MONDO_0005180,Parkinson disease
296,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT02549573'],MONDO_0005180,Parkinson disease
297,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
298,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,4.0,['NCT01216904'],MONDO_0005180,Parkinson disease
299,MTNR1B,melatonin receptor 1B,RAMELTEON,Small molecule,CHEMBL1218,4.0,['NCT00462254'],MONDO_0005180,Parkinson disease
300,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0005180,Parkinson disease
301,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
302,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT01789385', 'NCT01721460', 'NCT02256319']",MONDO_0005180,Parkinson disease
303,ADRA2B,adrenoceptor alpha 2B,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
304,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT04387773', 'NCT00632762', 'NCT01313845', 'NCT01071395']",MONDO_0005180,Parkinson disease
305,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,['NCT06236230'],MONDO_0005180,Parkinson disease
306,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,[],MONDO_0005180,Parkinson disease
307,DRD2,dopamine receptor D2,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT01673724', 'NCT02233023']",MONDO_0005180,Parkinson disease
308,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0005180,Parkinson disease
309,SLC6A2,solute carrier family 6 member 2,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
310,SCN2A,sodium voltage-gated channel alpha subunit 2,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
311,ADRB2,adrenoceptor beta 2,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
312,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02940912', 'NCT01770145']",MONDO_0005180,Parkinson disease
313,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
314,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
315,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,['NCT03968744'],MONDO_0005180,Parkinson disease
316,ADRA1D,adrenoceptor alpha 1D,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
317,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,[],MONDO_0005180,Parkinson disease
318,SCN7A,sodium voltage-gated channel alpha subunit 7,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
319,CHRM1,cholinergic receptor muscarinic 1,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0005180,Parkinson disease
320,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
321,SLC6A2,solute carrier family 6 member 2,ATOMOXETINE,Small molecule,CHEMBL641,4.0,['NCT01340885'],MONDO_0005180,Parkinson disease
322,MTNR1A,melatonin receptor 1A,RAMELTEON,Small molecule,CHEMBL1218,4.0,['NCT00462254'],MONDO_0005180,Parkinson disease
323,SCN4A,sodium voltage-gated channel alpha subunit 4,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
324,MAOB,monoamine oxidase B,SELEGILINE,Small molecule,CHEMBL972,4.0,[],MONDO_0005180,Parkinson disease
325,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,"['NCT00174239', 'NCT00642356']",MONDO_0005180,Parkinson disease
326,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,[],MONDO_0005180,Parkinson disease
327,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,"['NCT04952194', 'NCT06013956', 'NCT06236230']",MONDO_0005180,Parkinson disease
328,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT00399477', 'NCT00755027', 'NCT01497652', 'NCT01168596', 'NCT00902941', 'NCT01382342', 'NCT01049984', 'NCT01723228']",MONDO_0005180,Parkinson disease
329,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
330,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0005180,Parkinson disease
331,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT01782222', 'NCT01523301', 'NCT00594464', 'NCT03103919', 'NCT01744496', 'NCT01300819', 'NCT01711866']",MONDO_0005180,Parkinson disease
332,CHRM2,cholinergic receptor muscarinic 2,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0005180,Parkinson disease
333,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
334,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
335,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,[],MONDO_0005180,Parkinson disease
336,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
337,CLCN2,chloride voltage-gated channel 2,LUBIPROSTONE,Small molecule,CHEMBL1201134,4.0,['NCT00908076'],MONDO_0005180,Parkinson disease
338,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
339,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
340,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
341,CACNA1S,calcium voltage-gated channel subunit alpha1 S,ISRADIPINE,Small molecule,CHEMBL1648,3.0,['NCT02168842'],MONDO_0005180,Parkinson disease
342,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT02864004', 'NCT02339064']",MONDO_0005180,Parkinson disease
343,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT01723904', 'NCT04571164', 'NCT01646255', 'NCT00594165', 'NCT01631825', 'NCT00505687', 'NCT00474058', 'NCT00243971', 'NCT01646268', 'NCT00501969', 'NCT00242008', 'NCT00522379', 'NCT00599196', 'NCT01628926', 'NCT00243945', 'NCT00244387', 'NCT00594386', 'NCT00593606']",MONDO_0005180,Parkinson disease
344,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,3.0,"['NCT01063621', 'NCT00142545', 'NCT01058291', 'NCT00955318', 'NCT00145171', 'NCT00200525', 'NCT02006121']",MONDO_0005180,Parkinson disease
345,DRD3,dopamine receptor D3,PARDOPRUNOX,Small molecule,CHEMBL2103832,3.0,"['NCT00407095', 'NCT00335374', 'NCT00269516', 'NCT00406588', 'NCT00332917', 'NCT00134251']",MONDO_0005180,Parkinson disease
346,HTR1A,5-hydroxytryptamine receptor 1A,PARDOPRUNOX,Small molecule,CHEMBL2103832,3.0,"['NCT00406588', 'NCT00134251', 'NCT00407095', 'NCT00269516', 'NCT00335374', 'NCT00332917']",MONDO_0005180,Parkinson disease
347,ADORA2A,adenosine A2a receptor,CAFFEINE,Small molecule,CHEMBL113,3.0,['NCT01738178'],MONDO_0005180,Parkinson disease
348,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT00519532', 'NCT01536015']",MONDO_0005180,Parkinson disease
349,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,3.0,"['NCT04223193', 'NCT04201093']",MONDO_0005180,Parkinson disease
350,SLC6A2,solute carrier family 6 member 2,VENLAFAXINE HYDROCHLORIDE,Small molecule,CHEMBL1201066,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
351,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,3.0,"['NCT00145171', 'NCT00200525', 'NCT02006121', 'NCT01058291', 'NCT01063621', 'NCT00955318', 'NCT00142545']",MONDO_0005180,Parkinson disease
352,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,3.0,"['NCT01191944', 'NCT02172573', 'NCT00275275', 'NCT00466167', 'NCT00240409', 'NCT02177357', 'NCT00479401', 'NCT00335166', 'NCT00274131', 'NCT03329508', 'NCT01007864', 'NCT00601523', 'NCT00558025', 'NCT00577460']",MONDO_0005180,Parkinson disease
353,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE,Small molecule,CHEMBL636,3.0,['NCT04226248'],MONDO_0005180,Parkinson disease
354,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
355,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00286897', 'NCT00368108']",MONDO_0005180,Parkinson disease
356,HRH3,histamine receptor H3,PITOLISANT,Small molecule,CHEMBL462605,3.0,"['NCT01066442', 'NCT01036139']",MONDO_0005180,Parkinson disease
357,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
358,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,3.0,['NCT04760769'],MONDO_0005180,Parkinson disease
359,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT00243945', 'NCT00599196', 'NCT00242008', 'NCT01723904', 'NCT00522379', 'NCT00244387', 'NCT01646268', 'NCT00505687', 'NCT00474058', 'NCT01628926', 'NCT00501969', 'NCT00594386', 'NCT00594165', 'NCT01646255', 'NCT00593606', 'NCT04571164', 'NCT01631825', 'NCT00243971']",MONDO_0005180,Parkinson disease
360,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,3.0,"['NCT02337725', 'NCT01556165', 'NCT00203125', 'NCT01268891', 'NCT00203138', 'NCT00203034', 'NCT01155466', 'NCT01736891', 'NCT00203177', 'NCT02337764', 'NCT00256204', 'NCT02337751', 'NCT00203164', 'NCT03329508', 'NCT00203060', 'NCT01479530']",MONDO_0005180,Parkinson disease
361,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,3.0,['NCT04542499'],MONDO_0005180,Parkinson disease
362,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
363,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT02542696', 'NCT01058291', 'NCT00200525', 'NCT01504178', 'NCT02006121', 'NCT03391882', 'NCT00955318', 'NCT02469090', 'NCT01039090', 'NCT01063621', 'NCT00142545', 'NCT00145171']",MONDO_0005180,Parkinson disease
364,DRD2,dopamine receptor D2,SUMANIROLE,Small molecule,CHEMBL419792,3.0,"['NCT00058838', 'NCT00036218']",MONDO_0005180,Parkinson disease
365,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,3.0,"['NCT02352363', 'NCT01504178', 'NCT01646255', 'NCT02799381', 'NCT02549092', 'NCT00004733', 'NCT01568073', 'NCT02240030', 'NCT00406588', 'NCT01227655', 'NCT00660673', 'NCT01960842', 'NCT00357994', 'NCT02242487', 'NCT00099268', 'NCT00360568', 'NCT00660387', 'NCT04380142', 'NCT00134966', 'NCT00335153', 'NCT01736176']",MONDO_0005180,Parkinson disease
366,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,3.0,['NCT04226248'],MONDO_0005180,Parkinson disease
367,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,3.0,"['NCT00099268', 'NCT00360568', 'NCT01736176', 'NCT02549092', 'NCT00134966', 'NCT00660673', 'NCT01568073', 'NCT00357994', 'NCT02799381', 'NCT01960842', 'NCT00660387', 'NCT01227655', 'NCT00335153']",MONDO_0005180,Parkinson disease
368,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,['NCT02786667'],MONDO_0005180,Parkinson disease
369,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,['NCT02786667'],MONDO_0005180,Parkinson disease
370,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,3.0,"['NCT01174004', 'NCT00550238', 'NCT00477672', 'NCT00658567']",MONDO_0005180,Parkinson disease
371,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,3.0,['NCT04978597'],MONDO_0005180,Parkinson disease
372,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT02864004', 'NCT02339064']",MONDO_0005180,Parkinson disease
373,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
374,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00286897', 'NCT00368108']",MONDO_0005180,Parkinson disease
375,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,3.0,['NCT04232969'],MONDO_0005180,Parkinson disease
376,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,3.0,"['NCT02610231', 'NCT00957203', 'NCT00199407', 'NCT00203957', 'NCT00199394', 'NCT00955526', 'NCT00199420', 'NCT00199368', 'NCT01968031']",MONDO_0005180,Parkinson disease
377,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,3.0,"['NCT00577460', 'NCT00240409', 'NCT02172573', 'NCT01007864', 'NCT00558025', 'NCT03329508', 'NCT02177357', 'NCT00601523', 'NCT00466167', 'NCT00335166', 'NCT01191944', 'NCT00479401', 'NCT00275275', 'NCT00274131']",MONDO_0005180,Parkinson disease
378,OPRD1,opioid receptor delta 1,NALOXONE,Small molecule,CHEMBL80,3.0,['NCT01439100'],MONDO_0005180,Parkinson disease
379,SNAP25,synaptosome associated protein 25,INCOBOTULINUMTOXINA,Unknown,CHEMBL2108035,3.0,['NCT00909883'],MONDO_0005180,Parkinson disease
380,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN TARTRATE,Small molecule,CHEMBL2448613,3.0,"['NCT00477672', 'NCT00550238', 'NCT00658567', 'NCT01174004']",MONDO_0005180,Parkinson disease
381,ADORA2B,adenosine A2b receptor,CAFFEINE,Small molecule,CHEMBL113,3.0,['NCT01738178'],MONDO_0005180,Parkinson disease
382,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00360412', 'NCT00505622', 'NCT00360308']",MONDO_0005180,Parkinson disease
383,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT01929317'],MONDO_0005180,Parkinson disease
384,ADORA2A,adenosine A2a receptor,PRELADENANT,Small molecule,CHEMBL240624,3.0,"['NCT01155466', 'NCT01227265']",MONDO_0005180,Parkinson disease
385,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
386,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00360412', 'NCT00360308', 'NCT00505622']",MONDO_0005180,Parkinson disease
387,ADORA2A,adenosine A2a receptor,PRELADENANT,Small molecule,CHEMBL240624,3.0,"['NCT01215227', 'NCT01155479']",MONDO_0005180,Parkinson disease
388,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
389,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT01536015', 'NCT00519532']",MONDO_0005180,Parkinson disease
390,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00286897', 'NCT00368108']",MONDO_0005180,Parkinson disease
391,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00360308', 'NCT00360412', 'NCT00505622']",MONDO_0005180,Parkinson disease
392,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,3.0,['NCT04760769'],MONDO_0005180,Parkinson disease
393,ADRB1,adrenoceptor beta 1,DOPAMINE HYDROCHLORIDE,Small molecule,CHEMBL1557,3.0,['NCT01039090'],MONDO_0005180,Parkinson disease
394,CACNA1F,calcium voltage-gated channel subunit alpha1 F,ISRADIPINE,Small molecule,CHEMBL1648,3.0,['NCT02168842'],MONDO_0005180,Parkinson disease
395,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,3.0,"['NCT00465452', 'NCT00139880', 'NCT01039090', 'NCT00139867', 'NCT00038116']",MONDO_0005180,Parkinson disease
396,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,3.0,['NCT06068465'],MONDO_0005180,Parkinson disease
397,DRD4,dopamine receptor D4,BROMOCRIPTINE,Small molecule,CHEMBL493,3.0,"['NCT02172573', 'NCT00240409']",MONDO_0005180,Parkinson disease
398,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT01929317'],MONDO_0005180,Parkinson disease
399,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,3.0,"['NCT01960842', 'NCT00134966', 'NCT01227655', 'NCT00660387', 'NCT01568073', 'NCT00660673', 'NCT01736176', 'NCT00099268', 'NCT02549092', 'NCT00357994', 'NCT02799381', 'NCT00335153', 'NCT00360568']",MONDO_0005180,Parkinson disease
400,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
401,DRD3,dopamine receptor D3,BROMOCRIPTINE,Small molecule,CHEMBL493,3.0,"['NCT00240409', 'NCT02172573']",MONDO_0005180,Parkinson disease
402,SLC6A4,solute carrier family 6 member 4,VENLAFAXINE,Small molecule,CHEMBL637,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
403,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,3.0,['NCT00165815'],MONDO_0005180,Parkinson disease
404,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
405,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,3.0,"['NCT02615873', 'NCT02605434']",MONDO_0005180,Parkinson disease
406,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,3.0,"['NCT00256204', 'NCT00203060', 'NCT02337764', 'NCT00203177', 'NCT00203164', 'NCT02337751', 'NCT00203125', 'NCT00203138', 'NCT01479530', 'NCT00203034', 'NCT02337725']",MONDO_0005180,Parkinson disease
407,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,3.0,['NCT04542499'],MONDO_0005180,Parkinson disease
408,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,3.0,"['NCT01286935', 'NCT01187966', 'NCT00642889', 'NCT03881371', 'NCT00605683', 'NCT00643045']",MONDO_0005180,Parkinson disease
409,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
410,CNR1,cannabinoid receptor 1,NABILONE,Small molecule,CHEMBL2218896,3.0,['NCT03773796'],MONDO_0005180,Parkinson disease
411,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,3.0,['NCT01014858'],MONDO_0005180,Parkinson disease
412,SLC6A2,solute carrier family 6 member 2,AMPRELOXETINE,Small molecule,CHEMBL4297646,3.0,['NCT03829657'],MONDO_0005180,Parkinson disease
413,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,3.0,['NCT02605434'],MONDO_0005180,Parkinson disease
414,OPRK1,opioid receptor kappa 1,NALOXONE,Small molecule,CHEMBL80,3.0,['NCT01439100'],MONDO_0005180,Parkinson disease
415,SLC6A2,solute carrier family 6 member 2,VENLAFAXINE,Small molecule,CHEMBL637,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
416,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,3.0,"['NCT00623103', 'NCT00767091']",MONDO_0005180,Parkinson disease
417,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT01058291', 'NCT01063621', 'NCT00142545', 'NCT00145171', 'NCT03391882', 'NCT00200525', 'NCT02542696', 'NCT01504178', 'NCT02469090', 'NCT00955318', 'NCT02006121', 'NCT01039090']",MONDO_0005180,Parkinson disease
418,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,"['NCT00823836', 'NCT01007864']",MONDO_0005180,Parkinson disease
419,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,3.0,"['NCT00650104', 'NCT00381472', 'NCT00823836', 'NCT00363727', 'NCT00036218', 'NCT00331149', 'NCT01536574', 'NCT01154166', 'NCT00632736', 'NCT01628926', 'NCT01007864', 'NCT00275275']",MONDO_0005180,Parkinson disease
420,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
421,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,3.0,['NCT00360308'],MONDO_0005180,Parkinson disease
422,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00360412', 'NCT00505622', 'NCT00360308']",MONDO_0005180,Parkinson disease
423,CACNA1C,calcium voltage-gated channel subunit alpha1 C,ISRADIPINE,Small molecule,CHEMBL1648,3.0,['NCT02168842'],MONDO_0005180,Parkinson disease
424,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
425,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT00243945', 'NCT00474058', 'NCT00594386', 'NCT01646255', 'NCT00505687', 'NCT00243971', 'NCT00593606', 'NCT01631825', 'NCT00522379', 'NCT00242008', 'NCT01646268', 'NCT00244387', 'NCT04571164', 'NCT00501969', 'NCT01723904', 'NCT00599196', 'NCT01628926', 'NCT00594165']",MONDO_0005180,Parkinson disease
426,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
427,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT01929317'],MONDO_0005180,Parkinson disease
428,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,3.0,['NCT00275275'],MONDO_0005180,Parkinson disease
429,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,"['NCT00823836', 'NCT01007864']",MONDO_0005180,Parkinson disease
430,SLC6A2,solute carrier family 6 member 2,DULOXETINE,Small molecule,CHEMBL1175,3.0,['NCT01504178'],MONDO_0005180,Parkinson disease
431,DRD2,dopamine receptor D2,SUMANIROLE,Small molecule,CHEMBL419792,3.0,['NCT00036205'],MONDO_0005180,Parkinson disease
432,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
433,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
434,ADORA2A,adenosine A2a receptor,TOZADENANT,Small molecule,CHEMBL2105747,3.0,"['NCT02453386', 'NCT03051607']",MONDO_0005180,Parkinson disease
435,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,['NCT02786667'],MONDO_0005180,Parkinson disease
436,ADORA3,adenosine A3 receptor,CAFFEINE,Small molecule,CHEMBL113,3.0,['NCT01738178'],MONDO_0005180,Parkinson disease
437,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,3.0,"['NCT02605434', 'NCT02615873']",MONDO_0005180,Parkinson disease
438,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,3.0,['NCT00275275'],MONDO_0005180,Parkinson disease
439,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
440,CACNA1D,calcium voltage-gated channel subunit alpha1 D,ISRADIPINE,Small molecule,CHEMBL1648,3.0,['NCT02168842'],MONDO_0005180,Parkinson disease
441,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT02339064', 'NCT02864004']",MONDO_0005180,Parkinson disease
442,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN TARTRATE,Small molecule,CHEMBL2448613,3.0,['NCT06068465'],MONDO_0005180,Parkinson disease
443,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
444,SLC6A4,solute carrier family 6 member 4,PAROXETINE,Small molecule,CHEMBL490,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
445,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,3.0,"['NCT00955318', 'NCT00200525', 'NCT02006121', 'NCT01058291', 'NCT00145171', 'NCT01063621', 'NCT00142545']",MONDO_0005180,Parkinson disease
446,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,3.0,"['NCT00363727', 'NCT00331149', 'NCT01536574', 'NCT01154166', 'NCT00650104', 'NCT00823836', 'NCT00036218', 'NCT00275275', 'NCT01628926', 'NCT01007864', 'NCT00632736', 'NCT00381472']",MONDO_0005180,Parkinson disease
447,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT00519532', 'NCT01536015']",MONDO_0005180,Parkinson disease
448,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00368108', 'NCT00286897']",MONDO_0005180,Parkinson disease
449,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,3.0,"['NCT01155479', 'NCT01215227']",MONDO_0005180,Parkinson disease
450,SLC6A4,solute carrier family 6 member 4,DULOXETINE,Small molecule,CHEMBL1175,3.0,['NCT01504178'],MONDO_0005180,Parkinson disease
451,SLC6A4,solute carrier family 6 member 4,VENLAFAXINE HYDROCHLORIDE,Small molecule,CHEMBL1201066,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
452,DRD2,dopamine receptor D2,BROMOCRIPTINE,Small molecule,CHEMBL493,3.0,"['NCT02172573', 'NCT00240409']",MONDO_0005180,Parkinson disease
453,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
454,OPRM1,opioid receptor mu 1,NALOXONE,Small molecule,CHEMBL80,3.0,['NCT01439100'],MONDO_0005180,Parkinson disease
455,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,"['NCT00823836', 'NCT01007864']",MONDO_0005180,Parkinson disease
456,DRD2,dopamine receptor D2,PARDOPRUNOX,Small molecule,CHEMBL2103832,3.0,"['NCT00335374', 'NCT00406588', 'NCT00332917', 'NCT00407095', 'NCT00134251', 'NCT00269516']",MONDO_0005180,Parkinson disease
457,OPRM1,opioid receptor mu 1,OXYCODONE,Small molecule,CHEMBL656,3.0,['NCT01439100'],MONDO_0005180,Parkinson disease
458,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
459,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,3.0,"['NCT02615873', 'NCT02605434']",MONDO_0005180,Parkinson disease
460,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,3.0,"['NCT00650104', 'NCT00275275', 'NCT01154166', 'NCT00331149', 'NCT00036218', 'NCT00823836', 'NCT00363727', 'NCT01007864', 'NCT00381472', 'NCT00632736', 'NCT01628926', 'NCT01536574']",MONDO_0005180,Parkinson disease
461,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,3.0,"['NCT00099268', 'NCT01227655', 'NCT01568073', 'NCT00134966']",MONDO_0005180,Parkinson disease
462,HTR1A,5-hydroxytryptamine receptor 1A,BUSPIRONE,Small molecule,CHEMBL49,3.0,['NCT02617017'],MONDO_0005180,Parkinson disease
463,ADORA1,adenosine A1 receptor,CAFFEINE,Small molecule,CHEMBL113,3.0,['NCT01738178'],MONDO_0005180,Parkinson disease
464,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,3.0,"['NCT00865579', 'NCT01028586']",MONDO_0005180,Parkinson disease
465,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,3.0,"['NCT04201093', 'NCT04223193']",MONDO_0005180,Parkinson disease
466,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,3.0,['NCT00199381'],MONDO_0005180,Parkinson disease
467,DDC,dopa decarboxylase,BENSERAZIDE,Small molecule,CHEMBL1096979,3.0,"['NCT01568073', 'NCT01227655']",MONDO_0005180,Parkinson disease
468,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,3.0,['NCT01851850'],MONDO_0005180,Parkinson disease
469,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,3.0,"['NCT01007864', 'NCT00479401', 'NCT00275275', 'NCT01191944', 'NCT02172573', 'NCT00466167', 'NCT00558025', 'NCT00601523', 'NCT00240409', 'NCT02177357', 'NCT00335166', 'NCT00577460', 'NCT03329508', 'NCT00274131']",MONDO_0005180,Parkinson disease
470,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
471,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE,Small molecule,CHEMBL636,3.0,"['NCT00623103', 'NCT00767091']",MONDO_0005180,Parkinson disease
472,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT02006121', 'NCT02542696', 'NCT00955318', 'NCT00142545', 'NCT01039090', 'NCT02469090', 'NCT03391882', 'NCT01063621', 'NCT01058291', 'NCT00145171', 'NCT00200525', 'NCT01504178']",MONDO_0005180,Parkinson disease
473,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,3.0,['NCT00275275'],MONDO_0005180,Parkinson disease
474,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00758368', 'NCT00472355']",MONDO_0005180,Parkinson disease
475,NDUFB8,NADH:ubiquinone oxidoreductase subunit B8,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
476,ADORA2A,adenosine A2a receptor,VIPADENANT,Small molecule,CHEMBL447664,2.0,"['NCT00438607', 'NCT00442780']",MONDO_0005180,Parkinson disease
477,PDE8B,phosphodiesterase 8B,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
478,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
479,GLP1R,glucagon like peptide 1 receptor,SEMAGLUTIDE,Protein,CHEMBL2108724,2.0,['NCT03659682'],MONDO_0005180,Parkinson disease
480,UGCG,UDP-glucose ceramide glucosyltransferase,VENGLUSTAT,Small molecule,CHEMBL4297611,2.0,['NCT02906020'],MONDO_0005180,Parkinson disease
481,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,2.0,"['NCT00873392', 'NCT03865121']",MONDO_0005180,Parkinson disease
482,DRD2,dopamine receptor D2,SARIZOTAN HYDROCHLORIDE,Small molecule,CHEMBL2146110,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
483,ADRA1D,adrenoceptor alpha 1D,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
484,SCN4A,sodium voltage-gated channel alpha subunit 4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
485,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,2.0,"['NCT02847650', 'NCT03185481', 'NCT02687542']",MONDO_0005180,Parkinson disease
486,BCR,BCR activator of RhoGEF and GTPase,RADOTINIB,Small molecule,CHEMBL4297524,2.0,['NCT04691661'],MONDO_0005180,Parkinson disease
487,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,2.0,['NCT00562198'],MONDO_0005180,Parkinson disease
488,GRM4,glutamate metabotropic receptor 4,FOLIGLURAX,Small molecule,CHEMBL4089083,2.0,['NCT03331848'],MONDO_0005180,Parkinson disease
489,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,2.0,['NCT04164758'],MONDO_0005180,Parkinson disease
490,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,2.0,['NCT03301272'],MONDO_0005180,Parkinson disease
491,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
492,CHRM3,cholinergic receptor muscarinic 3,IPRATROPIUM BROMIDE,Small molecule,CHEMBL2134724,2.0,['NCT00296946'],MONDO_0005180,Parkinson disease
493,DRD2,dopamine receptor D2,APLINDORE,Small molecule,CHEMBL2110659,2.0,['NCT00809302'],MONDO_0005180,Parkinson disease
494,CYSLTR1,cysteinyl leukotriene receptor 1,MONTELUKAST,Small molecule,CHEMBL787,2.0,['NCT06113640'],MONDO_0005180,Parkinson disease
495,HTR1A,5-hydroxytryptamine receptor 1A,SARIZOTAN HYDROCHLORIDE,Small molecule,CHEMBL2146110,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
496,ACHE,acetylcholinesterase (Yt blood group),PYRIDOSTIGMINE,Small molecule,CHEMBL1115,2.0,['NCT01993680'],MONDO_0005180,Parkinson disease
497,NDUFS5,NADH:ubiquinone oxidoreductase subunit S5,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
498,ADRA2C,adrenoceptor alpha 2C,FIPAMEZOLE,Small molecule,CHEMBL1255582,2.0,['NCT00559871'],MONDO_0005180,Parkinson disease
499,PDE7A,phosphodiesterase 7A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
500,ROCK1,Rho associated coiled-coil containing protein kinase 1,FASUDIL,Small molecule,CHEMBL38380,2.0,['NCT05931575'],MONDO_0005180,Parkinson disease
501,NDUFA7,NADH:ubiquinone oxidoreductase subunit A7,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
502,NDUFB10,NADH:ubiquinone oxidoreductase subunit B10,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
503,MT-ND3,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
504,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
505,NDUFV1,NADH:ubiquinone oxidoreductase core subunit V1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
506,DRD2,dopamine receptor D2,SARIZOTAN,Small molecule,CHEMBL220808,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
507,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,"['NCT01628848', 'NCT01628965', 'NCT01634243', 'NCT00537485', 'NCT01631812', 'NCT00296192']",MONDO_0005180,Parkinson disease
508,CSF3R,colony stimulating factor 3 receptor,FILGRASTIM,Protein,CHEMBL1201567,2.0,['NCT01227681'],MONDO_0005180,Parkinson disease
509,SCN10A,sodium voltage-gated channel alpha subunit 10,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
510,PDE4B,phosphodiesterase 4B,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
511,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,KETAMINE,Small molecule,CHEMBL742,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
512,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
513,SLC6A4,solute carrier family 6 member 4,DULOXETINE,Small molecule,CHEMBL1175,2.0,['NCT02857244'],MONDO_0005180,Parkinson disease
514,COMT,catechol-O-methyltransferase,NEBICAPONE,Small molecule,CHEMBL160038,2.0,['NCT03103399'],MONDO_0005180,Parkinson disease
515,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,2.0,"['NCT03292016', 'NCT00200512', 'NCT00610103']",MONDO_0005180,Parkinson disease
516,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,2.0,['NCT03576638'],MONDO_0005180,Parkinson disease
517,NDUFB11,NADH:ubiquinone oxidoreductase subunit B11,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
518,HTR1A,5-hydroxytryptamine receptor 1A,PARDOPRUNOX,Small molecule,CHEMBL2103832,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
519,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT02347059'],MONDO_0005180,Parkinson disease
520,NDUFAB1,NADH:ubiquinone oxidoreductase subunit AB1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
521,SCN8A,sodium voltage-gated channel alpha subunit 8,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
522,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,2.0,['NCT01971242'],MONDO_0005180,Parkinson disease
523,NDUFV3,NADH:ubiquinone oxidoreductase subunit V3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
524,SCN11A,sodium voltage-gated channel alpha subunit 11,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
525,PPARA,peroxisome proliferator activated receptor alpha,GEMFIBROZIL,Small molecule,CHEMBL457,2.0,['NCT05931484'],MONDO_0005180,Parkinson disease
526,ADRA2B,adrenoceptor alpha 2B,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
527,ESR2,estrogen receptor 2,"ESTROGENS, CONJUGATED",Unknown,CHEMBL1201649,2.0,['NCT00234676'],MONDO_0005180,Parkinson disease
528,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,2.0,"['NCT00460148', 'NCT00434304']",MONDO_0005180,Parkinson disease
529,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,2.0,"['NCT02450786', 'NCT02415062']",MONDO_0005180,Parkinson disease
530,NDUFB4,NADH:ubiquinone oxidoreductase subunit B4,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
531,NDUFA13,NADH:ubiquinone oxidoreductase subunit A13,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
532,DRD2,dopamine receptor D2,DOMPERIDONE,Small molecule,CHEMBL219916,2.0,['NCT00006077'],MONDO_0005180,Parkinson disease
533,ESR1,estrogen receptor 1,"ESTROGENS, CONJUGATED",Unknown,CHEMBL1201649,2.0,['NCT00234676'],MONDO_0005180,Parkinson disease
534,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,"['NCT01968460', 'NCT00560508', 'NCT03845387']",MONDO_0005180,Parkinson disease
535,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT00165789', 'NCT01172379']",MONDO_0005180,Parkinson disease
536,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
537,ADORA1,adenosine A1 receptor,CAFFEINE,Small molecule,CHEMBL113,2.0,"['NCT00459420', 'NCT01190735']",MONDO_0005180,Parkinson disease
538,ADRA2B,adrenoceptor alpha 2B,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
539,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,2.0,"['NCT00089622', 'NCT01568034', 'NCT04778176', 'NCT00076674', 'NCT00009048', 'NCT01777555', 'NCT00040209', 'NCT02577523', 'NCT01617135', 'NCT03541356', 'NCT01171313', 'NCT03000569', 'NCT03007888', 'NCT02601586', 'NCT01883505', 'NCT01283594', 'NCT02764125', 'NCT02271503', 'NCT00006337', 'NCT00918177', 'NCT00745277', 'NCT00013624', 'NCT01568047', 'NCT00086294', 'NCT00279825', 'NCT00006077', 'NCT00558337', 'NCT03103399', 'NCT02641054', 'NCT00108667', 'NCT01479127', 'NCT01515410', 'NCT00253084']",MONDO_0005180,Parkinson disease
540,ADRA2C,adrenoceptor alpha 2C,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
541,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
542,MT-ND1,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
543,NDUFA8,NADH:ubiquinone oxidoreductase subunit A8,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
544,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,REMIMAZOLAM,Small molecule,CHEMBL4297526,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
545,MTNR1A,melatonin receptor 1A,MELATONIN,Small molecule,CHEMBL45,2.0,['NCT04287543'],MONDO_0005180,Parkinson disease
546,GPD2,glycerol-3-phosphate dehydrogenase 2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
547,BCR,BCR activator of RhoGEF and GTPase,NILOTINIB,Small molecule,CHEMBL255863,2.0,['NCT02954978'],MONDO_0005180,Parkinson disease
548,PDE6C,phosphodiesterase 6C,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
549,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,2.0,"['NCT05036473', 'NCT06113640', 'NCT05781711', 'NCT05962957']",MONDO_0005180,Parkinson disease
550,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
551,NDUFA10,NADH:ubiquinone oxidoreductase subunit A10,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
552,SCN11A,sodium voltage-gated channel alpha subunit 11,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
553,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00472355', 'NCT00758368']",MONDO_0005180,Parkinson disease
554,ADRA2A,adrenoceptor alpha 2A,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
555,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,2.0,"['NCT02347059', 'NCT03576638']",MONDO_0005180,Parkinson disease
556,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,REMIMAZOLAM,Small molecule,CHEMBL4297526,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
557,NDUFB2,NADH:ubiquinone oxidoreductase subunit B2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
558,MAP3K11,mitogen-activated protein kinase kinase kinase 11,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
559,MT-ND6,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
560,ADORA2B,adenosine A2b receptor,CAFFEINE,Small molecule,CHEMBL113,2.0,"['NCT01190735', 'NCT00459420']",MONDO_0005180,Parkinson disease
561,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,ZOLPIDEM,Small molecule,CHEMBL911,2.0,['NCT03621046'],MONDO_0005180,Parkinson disease
562,ADORA2A,adenosine A2a receptor,CAFFEINE,Small molecule,CHEMBL113,2.0,"['NCT00459420', 'NCT01190735']",MONDO_0005180,Parkinson disease
563,SCN5A,sodium voltage-gated channel alpha subunit 5,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
564,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,2.0,"['NCT00873392', 'NCT03865121']",MONDO_0005180,Parkinson disease
565,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,['NCT00451633'],MONDO_0005180,Parkinson disease
566,DRD2,dopamine receptor D2,APLINDORE,Small molecule,CHEMBL2110659,2.0,['NCT00623324'],MONDO_0005180,Parkinson disease
567,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
568,PDE6D,phosphodiesterase 6D,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
569,DRD3,dopamine receptor D3,SARIZOTAN,Small molecule,CHEMBL220808,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
570,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,LOVASTATIN,Small molecule,CHEMBL503,2.0,['NCT03242499'],MONDO_0005180,Parkinson disease
571,BCR,BCR activator of RhoGEF and GTPase,NILOTINIB,Small molecule,CHEMBL255863,2.0,['NCT03205488'],MONDO_0005180,Parkinson disease
572,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
573,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
574,SCN7A,sodium voltage-gated channel alpha subunit 7,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
575,PDE10A,phosphodiesterase 10A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
576,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT00427011', 'NCT00566462', 'NCT01634360']",MONDO_0005180,Parkinson disease
577,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
578,GABRD,gamma-aminobutyric acid type A receptor subunit delta,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
579,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
580,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
581,NR3C2,nuclear receptor subfamily 3 group C member 2,FLUDROCORTISONE ACETATE,Small molecule,CHEMBL1201010,2.0,['NCT01993680'],MONDO_0005180,Parkinson disease
582,NDUFS3,NADH:ubiquinone oxidoreductase core subunit S3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
583,CHRM3,cholinergic receptor muscarinic 3,TROPICAMIDE,Small molecule,CHEMBL1200604,2.0,['NCT00761137'],MONDO_0005180,Parkinson disease
584,DRD3,dopamine receptor D3,SARIZOTAN HYDROCHLORIDE,Small molecule,CHEMBL2146110,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
585,SCN7A,sodium voltage-gated channel alpha subunit 7,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
586,PDE6B,phosphodiesterase 6B,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
587,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,['NCT00451633'],MONDO_0005180,Parkinson disease
588,SNAP25,synaptosome associated protein 25,INCOBOTULINUMTOXINA,Unknown,CHEMBL2108035,2.0,['NCT02419313'],MONDO_0005180,Parkinson disease
589,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,2.0,"['NCT02337738', 'NCT01968460', 'NCT02789020']",MONDO_0005180,Parkinson disease
590,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
591,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
592,NDUFA11,NADH:ubiquinone oxidoreductase subunit A11,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
593,ADRA1B,adrenoceptor alpha 1B,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
594,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,2.0,"['NCT00200512', 'NCT00610103', 'NCT03292016']",MONDO_0005180,Parkinson disease
595,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT04879134'],MONDO_0005180,Parkinson disease
596,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT02347059'],MONDO_0005180,Parkinson disease
597,SCN5A,sodium voltage-gated channel alpha subunit 5,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
598,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN TARTRATE,Small molecule,CHEMBL2448613,2.0,"['NCT01518309', 'NCT00086294']",MONDO_0005180,Parkinson disease
599,PDE6A,phosphodiesterase 6A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
600,NQO1,NAD(P)H quinone dehydrogenase 1,VATIQUINONE,Small molecule,CHEMBL1812161,2.0,['NCT01923584'],MONDO_0005180,Parkinson disease
601,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
602,MMP8,matrix metallopeptidase 8,DOXYCYCLINE ANHYDROUS,Small molecule,CHEMBL1433,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
603,NDUFS2,NADH:ubiquinone oxidoreductase core subunit S2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
604,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,2.0,"['NCT02847650', 'NCT03185481', 'NCT02687542']",MONDO_0005180,Parkinson disease
605,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,TRAXOPRODIL,Small molecule,CHEMBL17350,2.0,['NCT00163085'],MONDO_0005180,Parkinson disease
606,PDE5A,phosphodiesterase 5A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
607,MAP3K9,mitogen-activated protein kinase kinase kinase 9,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
608,NDUFS6,NADH:ubiquinone oxidoreductase subunit S6,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
609,SNCA,synuclein alpha,CINPANEMAB,Antibody,CHEMBL3833330,2.0,['NCT03318523'],MONDO_0005180,Parkinson disease
610,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,2.0,['NCT03576638'],MONDO_0005180,Parkinson disease
611,ADRA2C,adrenoceptor alpha 2C,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
612,SCN9A,sodium voltage-gated channel alpha subunit 9,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
613,ADRB2,adrenoceptor beta 2,CLENBUTEROL,Small molecule,CHEMBL49080,2.0,['NCT04935762'],MONDO_0005180,Parkinson disease
614,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,REMIMAZOLAM,Small molecule,CHEMBL4297526,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
615,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",NILOTINIB HYDROCHLORIDE MONOHYDRATE,Small molecule,CHEMBL1201740,2.0,['NCT02954978'],MONDO_0005180,Parkinson disease
616,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,2.0,['NCT02206620'],MONDO_0005180,Parkinson disease
617,NDUFS8,NADH:ubiquinone oxidoreductase core subunit S8,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
618,GABBR2,gamma-aminobutyric acid type B receptor subunit 2,SODIUM OXYBATE,Small molecule,CHEMBL1200682,2.0,"['NCT02111122', 'NCT00641186']",MONDO_0005180,Parkinson disease
619,INSR,insulin receptor,INSULIN HUMAN,Protein,CHEMBL1201631,2.0,['NCT04251585'],MONDO_0005180,Parkinson disease
620,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,2.0,['NCT04305002'],MONDO_0005180,Parkinson disease
621,PDE3B,phosphodiesterase 3B,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
622,SCN3A,sodium voltage-gated channel alpha subunit 3,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
623,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
624,NDUFB3,NADH:ubiquinone oxidoreductase subunit B3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
625,SCN1A,sodium voltage-gated channel alpha subunit 1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
626,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,2.0,['NCT01351168'],MONDO_0005180,Parkinson disease
627,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
628,MMP8,matrix metallopeptidase 8,DOXYCYCLINE,Small molecule,CHEMBL1200699,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
629,PDE1B,phosphodiesterase 1B,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
630,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00346827', 'NCT01693081', 'NCT03292016', 'NCT03187301', 'NCT00040209', 'NCT00200512', 'NCT02228590', 'NCT00610103', 'NCT01683292']",MONDO_0005180,Parkinson disease
631,SLC6A2,solute carrier family 6 member 2,TESOFENSINE,Small molecule,CHEMBL3989690,2.0,"['NCT00006077', 'NCT00148486', 'NCT00148512']",MONDO_0005180,Parkinson disease
632,MMP1,matrix metallopeptidase 1,DOXYCYCLINE ANHYDROUS,Small molecule,CHEMBL1433,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
633,OPRM1,opioid receptor mu 1,OXYCODONE,Small molecule,CHEMBL656,2.0,['NCT02601586'],MONDO_0005180,Parkinson disease
634,ADRB2,adrenoceptor beta 2,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
635,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,2.0,['NCT01174810'],MONDO_0005180,Parkinson disease
636,NDUFAF1,NADH:ubiquinone oxidoreductase complex assembly factor 1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
637,HTR1A,5-hydroxytryptamine receptor 1A,SARIZOTAN,Small molecule,CHEMBL220808,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
638,CA2,carbonic anhydrase 2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
639,CNR1,cannabinoid receptor 1,NABILONE,Small molecule,CHEMBL2218896,2.0,['NCT03769896'],MONDO_0005180,Parkinson disease
640,DRD2,dopamine receptor D2,QUETIAPINE,Small molecule,CHEMBL716,2.0,['NCT04164758'],MONDO_0005180,Parkinson disease
641,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
642,PDE6H,phosphodiesterase 6H,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
643,ADORA2A,adenosine A2a receptor,PRELADENANT,Small molecule,CHEMBL240624,2.0,['NCT01294800'],MONDO_0005180,Parkinson disease
644,OPRL1,opioid related nociceptin receptor 1,LY-2940094,Small molecule,CHEMBL3304244,2.0,['NCT03608371'],MONDO_0005180,Parkinson disease
645,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
646,SCN2A,sodium voltage-gated channel alpha subunit 2,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
647,ADRB1,adrenoceptor beta 1,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
648,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,ZOLPIDEM,Small molecule,CHEMBL911,2.0,['NCT01351168'],MONDO_0005180,Parkinson disease
649,PDE5A,phosphodiesterase 5A,SILDENAFIL,Small molecule,CHEMBL192,2.0,['NCT02162979'],MONDO_0005180,Parkinson disease
650,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,"['NCT03845387', 'NCT01968460', 'NCT00560508']",MONDO_0005180,Parkinson disease
651,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
652,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,2.0,['NCT00359723'],MONDO_0005180,Parkinson disease
653,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
654,NDUFB9,NADH:ubiquinone oxidoreductase subunit B9,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
655,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,"['NCT01968460', 'NCT00560508', 'NCT03845387']",MONDO_0005180,Parkinson disease
656,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
657,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,2.0,"['NCT06113640', 'NCT05036473', 'NCT05962957', 'NCT05781711']",MONDO_0005180,Parkinson disease
658,NDUFB5,NADH:ubiquinone oxidoreductase subunit B5,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
659,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
660,GABRP,gamma-aminobutyric acid type A receptor subunit pi,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
661,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,2.0,['NCT03947216'],MONDO_0005180,Parkinson disease
662,VDR,vitamin D receptor,CHOLECALCIFEROL,Small molecule,CHEMBL1042,2.0,"['NCT00907972', 'NCT01119131']",MONDO_0005180,Parkinson disease
663,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",NILOTINIB,Small molecule,CHEMBL255863,2.0,['NCT02954978'],MONDO_0005180,Parkinson disease
664,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,2.0,"['NCT00460148', 'NCT00434304']",MONDO_0005180,Parkinson disease
665,HTR2C,5-hydroxytryptamine receptor 2C,QUETIAPINE,Small molecule,CHEMBL716,2.0,['NCT04164758'],MONDO_0005180,Parkinson disease
666,PDE9A,phosphodiesterase 9A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
667,SV2A,synaptic vesicle glycoprotein 2A,LEVETIRACETAM,Small molecule,CHEMBL1286,2.0,['NCT00160576'],MONDO_0005180,Parkinson disease
668,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,2.0,['NCT01560754'],MONDO_0005180,Parkinson disease
669,NDUFS1,NADH:ubiquinone oxidoreductase core subunit S1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
670,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
671,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,['NCT02103465'],MONDO_0005180,Parkinson disease
672,CACNA1C,calcium voltage-gated channel subunit alpha1 C,ISRADIPINE,Small molecule,CHEMBL1648,2.0,"['NCT00909545', 'NCT00753636']",MONDO_0005180,Parkinson disease
673,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,TALAMPANEL,Small molecule,CHEMBL61872,2.0,"['NCT00004576', 'NCT00108667']",MONDO_0005180,Parkinson disease
674,PDE2A,phosphodiesterase 2A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
675,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
676,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
677,ADRB1,adrenoceptor beta 1,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
678,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,2.0,['NCT00562198'],MONDO_0005180,Parkinson disease
679,MT-ND5,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
680,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT02347059'],MONDO_0005180,Parkinson disease
681,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,REMIMAZOLAM,Small molecule,CHEMBL4297526,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
682,NDUFA1,NADH:ubiquinone oxidoreductase subunit A1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
683,SCN3A,sodium voltage-gated channel alpha subunit 3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
684,NDUFB1,NADH:ubiquinone oxidoreductase subunit B1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
685,NDUFC1,NADH:ubiquinone oxidoreductase subunit C1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
686,ADRA2A,adrenoceptor alpha 2A,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
687,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT00165789', 'NCT01172379']",MONDO_0005180,Parkinson disease
688,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,2.0,"['NCT03292016', 'NCT00200512', 'NCT00610103']",MONDO_0005180,Parkinson disease
689,ADRB2,adrenoceptor beta 2,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
690,MMP13,matrix metallopeptidase 13,DOXYCYCLINE ANHYDROUS,Small molecule,CHEMBL1433,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
691,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT02702076'],MONDO_0005180,Parkinson disease
692,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,KETAMINE,Small molecule,CHEMBL742,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
693,PPARG,peroxisome proliferator activated receptor gamma,PIOGLITAZONE,Small molecule,CHEMBL595,2.0,['NCT01280123'],MONDO_0005180,Parkinson disease
694,NDUFB6,NADH:ubiquinone oxidoreductase subunit B6,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
695,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,2.0,"['NCT00200447', 'NCT02834507', 'NCT01568047', 'NCT03103399', 'NCT01568034', 'NCT00237263']",MONDO_0005180,Parkinson disease
696,NDUFA2,NADH:ubiquinone oxidoreductase subunit A2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
697,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,ZOLPIDEM,Small molecule,CHEMBL911,2.0,['NCT01351168'],MONDO_0005180,Parkinson disease
698,GRM5,glutamate metabotropic receptor 5,DIPRAGLURANT,Small molecule,CHEMBL2346738,2.0,['NCT01336088'],MONDO_0005180,Parkinson disease
699,MTNR1B,melatonin receptor 1B,MELATONIN,Small molecule,CHEMBL45,2.0,['NCT04287543'],MONDO_0005180,Parkinson disease
700,ADORA3,adenosine A3 receptor,CAFFEINE,Small molecule,CHEMBL113,2.0,"['NCT00459420', 'NCT01190735']",MONDO_0005180,Parkinson disease
701,SIGMAR1,sigma non-opioid intracellular receptor 1,DEXTROMETHORPHAN,Small molecule,CHEMBL52440,2.0,['NCT00001365'],MONDO_0005180,Parkinson disease
702,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
703,NDUFS7,NADH:ubiquinone oxidoreductase core subunit S7,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
704,ADRA1A,adrenoceptor alpha 1A,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
705,SLC6A2,solute carrier family 6 member 2,DULOXETINE,Small molecule,CHEMBL1175,2.0,['NCT02857244'],MONDO_0005180,Parkinson disease
706,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
707,SLC6A3,solute carrier family 6 member 3,TESOFENSINE,Small molecule,CHEMBL3989690,2.0,"['NCT00148512', 'NCT00006077', 'NCT00148486']",MONDO_0005180,Parkinson disease
708,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
709,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
710,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT01634360', 'NCT00566462', 'NCT00427011']",MONDO_0005180,Parkinson disease
711,GRIK5,glutamate ionotropic receptor kainate type subunit 5,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
712,DRD3,dopamine receptor D3,MESDOPETAM,Small molecule,CHEMBL4594447,2.0,"['NCT04435431', 'NCT03368170']",MONDO_0005180,Parkinson disease
713,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",RADOTINIB,Small molecule,CHEMBL4297524,2.0,['NCT04691661'],MONDO_0005180,Parkinson disease
714,MAP3K12,mitogen-activated protein kinase kinase kinase 12,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
715,GLP1R,glucagon like peptide 1 receptor,LIXISENATIDE,Protein,CHEMBL2108336,2.0,['NCT03439943'],MONDO_0005180,Parkinson disease
716,INSR,insulin receptor,INSULIN HUMAN,Protein,CHEMBL1201631,2.0,"['NCT02064166', 'NCT04687878']",MONDO_0005180,Parkinson disease
717,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,KETAMINE,Small molecule,CHEMBL742,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
718,ACHE,acetylcholinesterase (Yt blood group),PYRIDOSTIGMINE BROMIDE,Small molecule,CHEMBL812,2.0,['NCT01993680'],MONDO_0005180,Parkinson disease
719,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
720,DRD2,dopamine receptor D2,PARDOPRUNOX,Small molecule,CHEMBL2103832,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
721,NDUFB7,NADH:ubiquinone oxidoreductase subunit B7,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
722,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
723,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,DEXTROMETHORPHAN,Small molecule,CHEMBL52440,2.0,['NCT00001365'],MONDO_0005180,Parkinson disease
724,NDUFA6,NADH:ubiquinone oxidoreductase subunit A6,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
725,GLP1R,glucagon like peptide 1 receptor,LIRAGLUTIDE,Protein,CHEMBL4084119,2.0,['NCT02953665'],MONDO_0005180,Parkinson disease
726,HTR1A,5-hydroxytryptamine receptor 1A,PICLOZOTAN,Small molecule,CHEMBL345237,2.0,['NCT00623363'],MONDO_0005180,Parkinson disease
727,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
728,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,2.0,['NCT02668497'],MONDO_0005180,Parkinson disease
729,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,2.0,['NCT02857244'],MONDO_0005180,Parkinson disease
730,SCN1A,sodium voltage-gated channel alpha subunit 1,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
731,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
732,GRIK2,glutamate ionotropic receptor kainate type subunit 2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
733,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT01634360', 'NCT00427011', 'NCT00566462']",MONDO_0005180,Parkinson disease
734,ADORA2B,adenosine A2b receptor,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
735,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,REMIMAZOLAM,Small molecule,CHEMBL4297526,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
736,NDUFAF4,NADH:ubiquinone oxidoreductase complex assembly factor 4,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
737,ADORA2A,adenosine A2a receptor,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
738,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
739,DRD3,dopamine receptor D3,PARDOPRUNOX,Small molecule,CHEMBL2103832,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
740,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,VARENICLINE,Small molecule,CHEMBL1076903,2.0,"['NCT04403399', 'NCT01341080', 'NCT02933372']",MONDO_0005180,Parkinson disease
741,NDUFAF3,NADH:ubiquinone oxidoreductase complex assembly factor 3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
742,NDUFA3,NADH:ubiquinone oxidoreductase subunit A3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
743,GRIK3,glutamate ionotropic receptor kainate type subunit 3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
744,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,"['NCT01628965', 'NCT01628848', 'NCT01631812', 'NCT00296192', 'NCT00537485', 'NCT01634243']",MONDO_0005180,Parkinson disease
745,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
746,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,2.0,['NCT01264861'],MONDO_0005180,Parkinson disease
747,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT04879134'],MONDO_0005180,Parkinson disease
748,PDE1A,phosphodiesterase 1A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
749,NDUFA4,NDUFA4 mitochondrial complex associated,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
750,GABRD,gamma-aminobutyric acid type A receptor subunit delta,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
751,CNR1,cannabinoid receptor 1,CANNABIDIOL,Small molecule,CHEMBL190461,2.0,"['NCT02818777', 'NCT03582137']",MONDO_0005180,Parkinson disease
752,NDUFA5,NADH:ubiquinone oxidoreductase subunit A5,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
753,ADRB3,adrenoceptor beta 3,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
754,PDE3A,phosphodiesterase 3A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
755,MMP7,matrix metallopeptidase 7,DOXYCYCLINE ANHYDROUS,Small molecule,CHEMBL1433,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
756,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",VODOBATINIB,Small molecule,CHEMBL4130229,2.0,['NCT03655236'],MONDO_0005180,Parkinson disease
757,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,2.0,"['NCT01518309', 'NCT00086294']",MONDO_0005180,Parkinson disease
758,MT-ND2,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
759,CHRM1,cholinergic receptor muscarinic 1,TAK-071,Small molecule,CHEMBL4594351,2.0,['NCT04334317'],MONDO_0005180,Parkinson disease
760,SCN8A,sodium voltage-gated channel alpha subunit 8,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
761,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,['NCT02103465'],MONDO_0005180,Parkinson disease
762,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,2.0,"['NCT00456794', 'NCT00455507', 'NCT00199355', 'NCT00006337', 'NCT00955045', 'NCT00250393', 'NCT00456586']",MONDO_0005180,Parkinson disease
763,GABRP,gamma-aminobutyric acid type A receptor subunit pi,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
764,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,"['NCT01628848', 'NCT01634243', 'NCT00296192', 'NCT01628965', 'NCT01631812', 'NCT00537485']",MONDO_0005180,Parkinson disease
765,ADORA2A,adenosine A2a receptor,VIPADENANT,Small molecule,CHEMBL447664,2.0,['NCT00451815'],MONDO_0005180,Parkinson disease
766,GRIK1,glutamate ionotropic receptor kainate type subunit 1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
767,ADRA2B,adrenoceptor alpha 2B,FIPAMEZOLE,Small molecule,CHEMBL1255582,2.0,['NCT00559871'],MONDO_0005180,Parkinson disease
768,PDE4C,phosphodiesterase 4C,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
769,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,KETAMINE,Small molecule,CHEMBL742,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
770,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,2.0,['NCT02337738'],MONDO_0005180,Parkinson disease
771,BCR,BCR activator of RhoGEF and GTPase,VODOBATINIB,Small molecule,CHEMBL4130229,2.0,['NCT03655236'],MONDO_0005180,Parkinson disease
772,PDE7B,phosphodiesterase 7B,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
773,GABBR1,gamma-aminobutyric acid type B receptor subunit 1,OXYBATE,Small molecule,CHEMBL1342,2.0,"['NCT00641186', 'NCT02111122']",MONDO_0005180,Parkinson disease
774,SLC6A3,solute carrier family 6 member 3,MODAFINIL,Small molecule,CHEMBL1373,2.0,['NCT02857244'],MONDO_0005180,Parkinson disease
775,NDUFA9,NADH:ubiquinone oxidoreductase subunit A9,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
776,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,2.0,['NCT01560754'],MONDO_0005180,Parkinson disease
777,SNCA,synuclein alpha,PRASINEZUMAB,Antibody,CHEMBL4298077,2.0,"['NCT04777331', 'NCT03100149']",MONDO_0005180,Parkinson disease
778,NDUFA4L2,NDUFA4 mitochondrial complex associated like 2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
779,DRD4,dopamine receptor D4,SARIZOTAN,Small molecule,CHEMBL220808,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
780,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,TALAMPANEL,Small molecule,CHEMBL61872,2.0,"['NCT00108667', 'NCT00004576']",MONDO_0005180,Parkinson disease
781,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,2.0,"['NCT05781711', 'NCT05036473', 'NCT05962957', 'NCT06113640']",MONDO_0005180,Parkinson disease
782,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,2.0,"['NCT01568047', 'NCT04778176', 'NCT02271503', 'NCT01296464', 'NCT03007888', 'NCT00558337', 'NCT00279825', 'NCT01515410', 'NCT00253084', 'NCT03103399', 'NCT03541356', 'NCT00745277', 'NCT01617135', 'NCT01568034', 'NCT00918177', 'NCT01883505', 'NCT00200447', 'NCT02577523', 'NCT01766258', 'NCT01479127', 'NCT01399905', 'NCT01171313']",MONDO_0005180,Parkinson disease
783,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
784,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
785,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00040209', 'NCT00346827', 'NCT00610103', 'NCT00200512', 'NCT01693081', 'NCT03292016', 'NCT03187301', 'NCT02228590', 'NCT01683292']",MONDO_0005180,Parkinson disease
786,DRD2,dopamine receptor D2,PRIDOPIDINE,Small molecule,CHEMBL596802,2.0,['NCT03922711'],MONDO_0005180,Parkinson disease
787,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,KETAMINE,Small molecule,CHEMBL742,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
788,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,REMIMAZOLAM,Small molecule,CHEMBL4297526,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
789,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,['NCT00451633'],MONDO_0005180,Parkinson disease
790,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
791,SCN9A,sodium voltage-gated channel alpha subunit 9,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
792,NDUFV2,NADH:ubiquinone oxidoreductase core subunit V2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
793,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
794,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,2.0,['NCT01113320'],MONDO_0005180,Parkinson disease
795,PDE1C,phosphodiesterase 1C,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
796,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,2.0,"['NCT01515410', 'NCT02834507']",MONDO_0005180,Parkinson disease
797,PDE6G,phosphodiesterase 6G,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
798,SCN10A,sodium voltage-gated channel alpha subunit 10,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
799,SCN2A,sodium voltage-gated channel alpha subunit 2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
800,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,2.0,['NCT00562198'],MONDO_0005180,Parkinson disease
801,ADRA1D,adrenoceptor alpha 1D,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
802,MAP3K13,mitogen-activated protein kinase kinase kinase 13,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
803,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
804,SLC6A3,solute carrier family 6 member 3,MODAFINIL,Small molecule,CHEMBL1373,2.0,['NCT03083132'],MONDO_0005180,Parkinson disease
805,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
806,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT01634360', 'NCT00427011', 'NCT00566462']",MONDO_0005180,Parkinson disease
807,PDE4D,phosphodiesterase 4D,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
808,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,VARENICLINE,Small molecule,CHEMBL1076903,2.0,"['NCT04403399', 'NCT01341080', 'NCT02933372']",MONDO_0005180,Parkinson disease
809,MAP3K10,mitogen-activated protein kinase kinase kinase 10,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
810,MPO,myeloperoxidase,VERDIPERSTAT,Small molecule,CHEMBL4297594,2.0,"['NCT01603069', 'NCT01527695']",MONDO_0005180,Parkinson disease
811,ROCK2,Rho associated coiled-coil containing protein kinase 2,FASUDIL,Small molecule,CHEMBL38380,2.0,['NCT05931575'],MONDO_0005180,Parkinson disease
812,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,SIMVASTATIN,Small molecule,CHEMBL1064,2.0,['NCT02787590'],MONDO_0005180,Parkinson disease
813,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
814,CACNA1B,calcium voltage-gated channel subunit alpha1 B,LEVETIRACETAM,Small molecule,CHEMBL1286,2.0,['NCT00160576'],MONDO_0005180,Parkinson disease
815,NR1H4,nuclear receptor subfamily 1 group H member 4,URSODIOL,Small molecule,CHEMBL1551,2.0,['NCT03840005'],MONDO_0005180,Parkinson disease
816,CACNA1F,calcium voltage-gated channel subunit alpha1 F,ISRADIPINE,Small molecule,CHEMBL1648,2.0,"['NCT00753636', 'NCT00909545']",MONDO_0005180,Parkinson disease
817,SLC6A4,solute carrier family 6 member 4,CITALOPRAM,Small molecule,CHEMBL549,2.0,['NCT04497168'],MONDO_0005180,Parkinson disease
818,MMP1,matrix metallopeptidase 1,DOXYCYCLINE,Small molecule,CHEMBL1200699,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
819,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",NILOTINIB,Small molecule,CHEMBL255863,2.0,['NCT03205488'],MONDO_0005180,Parkinson disease
820,CACNA1D,calcium voltage-gated channel subunit alpha1 D,ISRADIPINE,Small molecule,CHEMBL1648,2.0,"['NCT00909545', 'NCT00753636']",MONDO_0005180,Parkinson disease
821,SLC6A4,solute carrier family 6 member 4,TESOFENSINE,Small molecule,CHEMBL3989690,2.0,"['NCT00006077', 'NCT00148486', 'NCT00148512']",MONDO_0005180,Parkinson disease
822,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT04879134'],MONDO_0005180,Parkinson disease
823,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT02702076'],MONDO_0005180,Parkinson disease
824,CACNA1S,calcium voltage-gated channel subunit alpha1 S,ISRADIPINE,Small molecule,CHEMBL1648,2.0,"['NCT00753636', 'NCT00909545']",MONDO_0005180,Parkinson disease
825,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT00165789', 'NCT01172379']",MONDO_0005180,Parkinson disease
826,GRM5,glutamate metabotropic receptor 5,MAVOGLURANT,Small molecule,CHEMBL3087515,2.0,"['NCT00986414', 'NCT00582673', 'NCT01092065']",MONDO_0005180,Parkinson disease
827,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
828,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
829,MT-ND4L,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
830,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,2.0,['NCT00359723'],MONDO_0005180,Parkinson disease
831,NDUFAF2,NADH:ubiquinone oxidoreductase complex assembly factor 2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
832,NDUFS4,NADH:ubiquinone oxidoreductase subunit S4,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
833,NDUFA12,NADH:ubiquinone oxidoreductase subunit A12,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
834,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT01172379', 'NCT00165789']",MONDO_0005180,Parkinson disease
835,GRIK4,glutamate ionotropic receptor kainate type subunit 4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
836,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,KETAMINE,Small molecule,CHEMBL742,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
837,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,['NCT02103465'],MONDO_0005180,Parkinson disease
838,ADRA1A,adrenoceptor alpha 1A,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
839,ADRB3,adrenoceptor beta 3,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
840,BCR,BCR activator of RhoGEF and GTPase,NILOTINIB HYDROCHLORIDE MONOHYDRATE,Small molecule,CHEMBL1201740,2.0,['NCT02954978'],MONDO_0005180,Parkinson disease
841,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,['NCT00451633'],MONDO_0005180,Parkinson disease
842,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00200512', 'NCT01693081', 'NCT00346827', 'NCT02228590', 'NCT00040209', 'NCT03187301', 'NCT01683292', 'NCT03292016', 'NCT00610103']",MONDO_0005180,Parkinson disease
843,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
844,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,KETAMINE,Small molecule,CHEMBL742,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
845,ADORA2A,adenosine A2a receptor,TOZADENANT,Small molecule,CHEMBL2105747,2.0,"['NCT00605553', 'NCT01283594']",MONDO_0005180,Parkinson disease
846,MMP7,matrix metallopeptidase 7,DOXYCYCLINE,Small molecule,CHEMBL1200699,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
847,ADRA1B,adrenoceptor alpha 1B,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
848,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,2.0,['NCT02347059'],MONDO_0005180,Parkinson disease
849,GABBR1,gamma-aminobutyric acid type B receptor subunit 1,SODIUM OXYBATE,Small molecule,CHEMBL1200682,2.0,"['NCT02111122', 'NCT00641186']",MONDO_0005180,Parkinson disease
850,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,ZOLPIDEM,Small molecule,CHEMBL911,2.0,['NCT03621046'],MONDO_0005180,Parkinson disease
851,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,2.0,"['NCT02577523', 'NCT03007888', 'NCT01515410', 'NCT00745277', 'NCT00558337', 'NCT01568034', 'NCT03541356', 'NCT01766258', 'NCT00279825', 'NCT01399905', 'NCT01883505', 'NCT01296464', 'NCT01479127', 'NCT01617135', 'NCT03103399', 'NCT01568047', 'NCT01171313', 'NCT00200447', 'NCT00918177', 'NCT04778176', 'NCT02271503', 'NCT00253084']",MONDO_0005180,Parkinson disease
852,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT02702076'],MONDO_0005180,Parkinson disease
853,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
854,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
855,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00472355', 'NCT00758368']",MONDO_0005180,Parkinson disease
856,GABBR2,gamma-aminobutyric acid type B receptor subunit 2,OXYBATE,Small molecule,CHEMBL1342,2.0,"['NCT02111122', 'NCT00641186']",MONDO_0005180,Parkinson disease
857,GLP1R,glucagon like peptide 1 receptor,PEGSEBRENATIDE,Protein,CHEMBL4650495,2.0,['NCT04154072'],MONDO_0005180,Parkinson disease
858,PDE8A,phosphodiesterase 8A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
859,CA4,carbonic anhydrase 4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
860,PDE4A,phosphodiesterase 4A,PENTOXIFYLLINE,Small molecule,CHEMBL628,2.0,['NCT05962957'],MONDO_0005180,Parkinson disease
861,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,2.0,"['NCT00460148', 'NCT00434304']",MONDO_0005180,Parkinson disease
862,DRD4,dopamine receptor D4,SARIZOTAN HYDROCHLORIDE,Small molecule,CHEMBL2146110,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
863,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
864,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,TRAXOPRODIL,Small molecule,CHEMBL17350,2.0,['NCT00163085'],MONDO_0005180,Parkinson disease
865,CHRM3,cholinergic receptor muscarinic 3,IPRATROPIUM,Small molecule,CHEMBL1621597,2.0,['NCT00296946'],MONDO_0005180,Parkinson disease
866,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,REMIMAZOLAM,Small molecule,CHEMBL4297526,2.0,['NCT06231563'],MONDO_0005180,Parkinson disease
867,HTR2A,5-hydroxytryptamine receptor 2A,QUETIAPINE,Small molecule,CHEMBL716,2.0,['NCT04164758'],MONDO_0005180,Parkinson disease
868,NDUFC2,NADH:ubiquinone oxidoreductase subunit C2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
869,MMP13,matrix metallopeptidase 13,DOXYCYCLINE,Small molecule,CHEMBL1200699,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
870,SCN4A,sodium voltage-gated channel alpha subunit 4,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
871,GRM4,glutamate metabotropic receptor 4,FOLIGLURAX,Small molecule,CHEMBL4089083,2.0,['NCT03162874'],MONDO_0005180,Parkinson disease
872,ADRA2A,adrenoceptor alpha 2A,FIPAMEZOLE,Small molecule,CHEMBL1255582,2.0,['NCT00559871'],MONDO_0005180,Parkinson disease
873,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,2.0,['NCT00562198'],MONDO_0005180,Parkinson disease
874,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
875,ADORA2A,adenosine A2a receptor,PBF-509,Small molecule,CHEMBL3694769,1.0,"['NCT01691924', 'NCT02111330']",MONDO_0005180,Parkinson disease
876,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,['NCT04183634'],MONDO_0005180,Parkinson disease
877,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,1.0,"['NCT01532141', 'NCT01879748', 'NCT01652313', 'NCT01532128']",MONDO_0005180,Parkinson disease
878,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
879,SCN10A,sodium voltage-gated channel alpha subunit 10,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
880,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
881,BCR,BCR activator of RhoGEF and GTPase,VODOBATINIB,Small molecule,CHEMBL4130229,1.0,['NCT02970019'],MONDO_0005180,Parkinson disease
882,IMPA1,inositol monophosphatase 1,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT06339034'],MONDO_0005180,Parkinson disease
883,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03462641', 'NCT03440112']",MONDO_0005180,Parkinson disease
884,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
885,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
886,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
887,GABRD,gamma-aminobutyric acid type A receptor subunit delta,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
888,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,1.0,['NCT04332276'],MONDO_0005180,Parkinson disease
889,GRM4,glutamate metabotropic receptor 4,FOLIGLURAX,Small molecule,CHEMBL4089083,1.0,"['NCT04322227', 'NCT04175132']",MONDO_0005180,Parkinson disease
890,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,1.0,"['NCT02169479', 'NCT02763839', 'NCT02169453', 'NCT01533077', 'NCT02774564', 'NCT03091868', 'NCT02812394']",MONDO_0005180,Parkinson disease
891,GSK3A,glycogen synthase kinase 3 alpha,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT06339034'],MONDO_0005180,Parkinson disease
892,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,1.0,"['NCT01533116', 'NCT03496870', 'NCT02169414', 'NCT03887884', 'NCT00845000', 'NCT02554734', 'NCT01070628', 'NCT00914602', 'NCT02312232', 'NCT02170376', 'NCT00491998', 'NCT06219915', 'NCT02486432', 'NCT01519284', 'NCT01484990', 'NCT00505843', 'NCT01229332', 'NCT04325503', 'NCT03140956']",MONDO_0005180,Parkinson disease
893,CSF2RA,colony stimulating factor 2 receptor subunit alpha,SARGRAMOSTIM,Protein,CHEMBL1201670,1.0,['NCT01882010'],MONDO_0005180,Parkinson disease
894,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
895,DRD1,dopamine receptor D1,MEVIDALEN,Small molecule,CHEMBL3421729,1.0,['NCT02562768'],MONDO_0005180,Parkinson disease
896,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
897,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,1.0,"['NCT05610189', 'NCT02224664', 'NCT05581823', 'NCT02373072', 'NCT04295642']",MONDO_0005180,Parkinson disease
898,SCN1A,sodium voltage-gated channel alpha subunit 1,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
899,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,"['NCT00666653', 'NCT04249544']",MONDO_0005180,Parkinson disease
900,IMPA1,inositol monophosphatase 1,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT04273932'],MONDO_0005180,Parkinson disease
901,PTGS1,prostaglandin-endoperoxide synthase 1,ACETAMINOPHEN,Small molecule,CHEMBL112,1.0,['NCT02305017'],MONDO_0005180,Parkinson disease
902,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
903,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
904,SNCA,synuclein alpha,PRASINEZUMAB,Antibody,CHEMBL4298077,1.0,"['NCT02095171', 'NCT02157714']",MONDO_0005180,Parkinson disease
905,SCN8A,sodium voltage-gated channel alpha subunit 8,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
906,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,1.0,['NCT03250117'],MONDO_0005180,Parkinson disease
907,NR1H4,nuclear receptor subfamily 1 group H member 4,URSODIOL,Small molecule,CHEMBL1551,1.0,['NCT02967250'],MONDO_0005180,Parkinson disease
908,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
909,ADORA2A,adenosine A2a receptor,CAFFEINE,Small molecule,CHEMBL113,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
910,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,1.0,"['NCT01435915', 'NCT01371682']",MONDO_0005180,Parkinson disease
911,SCN7A,sodium voltage-gated channel alpha subunit 7,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
912,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,1.0,"['NCT01435915', 'NCT01371682']",MONDO_0005180,Parkinson disease
913,SCN4A,sodium voltage-gated channel alpha subunit 4,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
914,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,"['NCT04249544', 'NCT00666653']",MONDO_0005180,Parkinson disease
915,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,['NCT04183634'],MONDO_0005180,Parkinson disease
916,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,['NCT04183634'],MONDO_0005180,Parkinson disease
917,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
918,RXRA,retinoid X receptor alpha,IRX-4204,Small molecule,CHEMBL75133,1.0,['NCT02438215'],MONDO_0005180,Parkinson disease
919,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,1.0,['NCT02174250'],MONDO_0005180,Parkinson disease
920,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,1.0,['NCT04127578'],MONDO_0005180,Parkinson disease
921,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,"['NCT04044547', 'NCT02230904', 'NCT04384666', 'NCT01964573', 'NCT02728947', 'NCT02055274', 'NCT00292227', 'NCT04045678', 'NCT01338896']",MONDO_0005180,Parkinson disease
922,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
923,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
924,RXRB,retinoid X receptor beta,IRX-4204,Small molecule,CHEMBL75133,1.0,['NCT02438215'],MONDO_0005180,Parkinson disease
925,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,REPAGLINIDE,Small molecule,CHEMBL1272,1.0,['NCT01536366'],MONDO_0005180,Parkinson disease
926,FKBP1A,FKBP prolyl isomerase 1A,SIROLIMUS,Small molecule,CHEMBL413,1.0,['NCT04127578'],MONDO_0005180,Parkinson disease
927,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
928,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,1.0,"['NCT04591535', 'NCT04513340', 'NCT05128175']",MONDO_0005180,Parkinson disease
929,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
930,GFRA1,GDNF family receptor alpha 1,LIATERMIN,Protein,CHEMBL2108380,1.0,"['NCT00115427', 'NCT00111982']",MONDO_0005180,Parkinson disease
931,SCN3A,sodium voltage-gated channel alpha subunit 3,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
932,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
933,SNCA,synuclein alpha,CINPANEMAB,Antibody,CHEMBL3833330,1.0,['NCT02459886'],MONDO_0005180,Parkinson disease
934,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,1.0,"['NCT03820037', 'NCT04265027', 'NCT03116295', 'NCT03496870', 'NCT03116308']",MONDO_0005180,Parkinson disease
935,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,1.0,"['NCT02486432', 'NCT02312232', 'NCT01519284', 'NCT04325503', 'NCT02554734', 'NCT02169414', 'NCT03140956', 'NCT06219915', 'NCT00491998', 'NCT01070628', 'NCT00914602', 'NCT03887884', 'NCT03496870', 'NCT00845000', 'NCT02170376', 'NCT01484990', 'NCT00505843', 'NCT01533116', 'NCT01229332']",MONDO_0005180,Parkinson disease
936,VKORC1,vitamin K epoxide reductase complex subunit 1,WARFARIN,Small molecule,CHEMBL1464,1.0,"['NCT02169440', 'NCT02305030']",MONDO_0005180,Parkinson disease
937,SCN11A,sodium voltage-gated channel alpha subunit 11,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
938,ADRA1A,adrenoceptor alpha 1A,TERAZOSIN,Small molecule,CHEMBL611,1.0,['NCT03905811'],MONDO_0005180,Parkinson disease
939,SCN9A,sodium voltage-gated channel alpha subunit 9,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
940,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,1.0,['NCT00957918'],MONDO_0005180,Parkinson disease
941,DRD3,dopamine receptor D3,MESDOPETAM,Small molecule,CHEMBL4594447,1.0,['NCT03531060'],MONDO_0005180,Parkinson disease
942,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,"['NCT02230904', 'NCT01964573', 'NCT02728947', 'NCT01338896', 'NCT04384666', 'NCT02055274', 'NCT00292227', 'NCT04044547', 'NCT04045678']",MONDO_0005180,Parkinson disease
943,GSK3B,glycogen synthase kinase 3 beta,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT04273932'],MONDO_0005180,Parkinson disease
944,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03462641', 'NCT03440112']",MONDO_0005180,Parkinson disease
945,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,"['NCT02230904', 'NCT02728947', 'NCT00292227', 'NCT01964573', 'NCT04045678', 'NCT01338896', 'NCT04384666', 'NCT04044547', 'NCT02055274']",MONDO_0005180,Parkinson disease
946,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,1.0,"['NCT04295642', 'NCT02373072', 'NCT05581823', 'NCT05610189', 'NCT02224664']",MONDO_0005180,Parkinson disease
947,ADORA2A,adenosine A2a receptor,PRELADENANT,Small molecule,CHEMBL240624,1.0,"['NCT01323855', 'NCT00845000']",MONDO_0005180,Parkinson disease
948,ABCC8,ATP binding cassette subfamily C member 8,REPAGLINIDE,Small molecule,CHEMBL1272,1.0,['NCT01536366'],MONDO_0005180,Parkinson disease
949,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,1.0,"['NCT04513340', 'NCT05128175', 'NCT04591535']",MONDO_0005180,Parkinson disease
950,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,ROSUVASTATIN,Small molecule,CHEMBL1496,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
951,TRPV1,transient receptor potential cation channel subfamily V member 1,ACETAMINOPHEN,Small molecule,CHEMBL112,1.0,['NCT02305017'],MONDO_0005180,Parkinson disease
952,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,1.0,['NCT03119636'],MONDO_0005180,Parkinson disease
953,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03462641', 'NCT03440112']",MONDO_0005180,Parkinson disease
954,CSF2RA,colony stimulating factor 2 receptor subunit alpha,SARGRAMOSTIM,Protein,CHEMBL1201670,1.0,['NCT03790670'],MONDO_0005180,Parkinson disease
955,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
956,ADORA1,adenosine A1 receptor,CAFFEINE,Small molecule,CHEMBL113,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
957,DRD2,dopamine receptor D2,ORDOPIDINE,Small molecule,CHEMBL3545010,1.0,['NCT01023282'],MONDO_0005180,Parkinson disease
958,GRM4,glutamate metabotropic receptor 4,FOLIGLURAX,Small molecule,CHEMBL4089083,1.0,['NCT02639221'],MONDO_0005180,Parkinson disease
959,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,1.0,['NCT03250117'],MONDO_0005180,Parkinson disease
960,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,1.0,['NCT00957918'],MONDO_0005180,Parkinson disease
961,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",VODOBATINIB,Small molecule,CHEMBL4130229,1.0,['NCT02970019'],MONDO_0005180,Parkinson disease
962,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
963,SCN2A,sodium voltage-gated channel alpha subunit 2,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
964,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
965,SNCA,synuclein alpha,CINPANEMAB,Antibody,CHEMBL3833330,1.0,['NCT03716570'],MONDO_0005180,Parkinson disease
966,SCN5A,sodium voltage-gated channel alpha subunit 5,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
967,ADRA1D,adrenoceptor alpha 1D,TERAZOSIN,Small molecule,CHEMBL611,1.0,['NCT03905811'],MONDO_0005180,Parkinson disease
968,EPOR,erythropoietin receptor,EPOETIN BETA,Protein,CHEMBL2109092,1.0,['NCT01010802'],MONDO_0005180,Parkinson disease
969,ADORA2B,adenosine A2b receptor,CAFFEINE,Small molecule,CHEMBL113,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
970,ADRA1B,adrenoceptor alpha 1B,TERAZOSIN,Small molecule,CHEMBL611,1.0,['NCT03905811'],MONDO_0005180,Parkinson disease
971,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,1.0,"['NCT03887884', 'NCT02312232', 'NCT02812394', 'NCT02778594', 'NCT03140956', 'NCT03496870', 'NCT01533116', 'NCT02486432', 'NCT00845000', 'NCT00505843', 'NCT01519284', 'NCT02554734', 'NCT03205956', 'NCT02807675', 'NCT02170376', 'NCT01026428', 'NCT01070628', 'NCT00914602', 'NCT02169414', 'NCT06219915', 'NCT01484990']",MONDO_0005180,Parkinson disease
972,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,1.0,['NCT03250117'],MONDO_0005180,Parkinson disease
973,GABRP,gamma-aminobutyric acid type A receptor subunit pi,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
974,PTGS2,prostaglandin-endoperoxide synthase 2,ACETAMINOPHEN,Small molecule,CHEMBL112,1.0,['NCT02305017'],MONDO_0005180,Parkinson disease
975,MPO,myeloperoxidase,VERDIPERSTAT,Small molecule,CHEMBL4297594,1.0,['NCT01457807'],MONDO_0005180,Parkinson disease
976,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,"['NCT04249544', 'NCT00666653']",MONDO_0005180,Parkinson disease
977,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
978,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
979,DDC,dopa decarboxylase,BENSERAZIDE,Small molecule,CHEMBL1096979,1.0,"['NCT02169414', 'NCT02778594', 'NCT01533116']",MONDO_0005180,Parkinson disease
980,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,1.0,['NCT01026428'],MONDO_0005180,Parkinson disease
981,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,1.0,"['NCT04591535', 'NCT05128175', 'NCT04513340']",MONDO_0005180,Parkinson disease
982,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,1.0,"['NCT01435915', 'NCT01371682']",MONDO_0005180,Parkinson disease
983,RXRG,retinoid X receptor gamma,IRX-4204,Small molecule,CHEMBL75133,1.0,['NCT02438215'],MONDO_0005180,Parkinson disease
984,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
985,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,1.0,['NCT03456687'],MONDO_0005180,Parkinson disease
986,GSK3B,glycogen synthase kinase 3 beta,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT06339034'],MONDO_0005180,Parkinson disease
987,ADORA3,adenosine A3 receptor,CAFFEINE,Small molecule,CHEMBL113,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
988,GSK3A,glycogen synthase kinase 3 alpha,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT04273932'],MONDO_0005180,Parkinson disease
989,COMT,catechol-O-methyltransferase,NEBICAPONE,Small molecule,CHEMBL160038,1.0,"['NCT03097211', 'NCT02772627']",MONDO_0005180,Parkinson disease
990,ADORA2A,adenosine A2a receptor,CIFORADENANT,Small molecule,CHEMBL4297184,1.0,"['NCT02764892', 'NCT01634568']",MONDO_0005180,Parkinson disease
991,FAAH,fatty acid amide hydrolase,ACETAMINOPHEN,Small molecule,CHEMBL112,1.0,['NCT02305017'],MONDO_0005180,Parkinson disease
992,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,BREXANOLONE,Small molecule,CHEMBL207538,1.0,['NCT06263010'],MONDO_0005180,Parkinson disease
993,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,1.0,"['NCT01532128', 'NCT01070628', 'NCT02305277', 'NCT02169453', 'NCT02305017', 'NCT01533077', 'NCT00491998', 'NCT02305316', 'NCT02305030', 'NCT03820037', 'NCT03094156', 'NCT01515891', 'NCT01532141', 'NCT02169414', 'NCT03091868', 'NCT02169895', 'NCT02169479', 'NCT02169466', 'NCT02092168', 'NCT01533116', 'NCT03119194', 'NCT02170376', 'NCT02071810', 'NCT02169440', 'NCT01519284', 'NCT01532115', 'NCT01520727', 'NCT01536366', 'NCT02554734', 'NCT01520987', 'NCT02101190', 'NCT02071823', 'NCT02096601']",MONDO_0005180,Parkinson disease
994,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
